Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/

CannaPharmaRx, Inc.

Early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. The Company is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology. Pharmaceutical company that is engaged in cannabinoid discovery, science, research and development. The Company has over 900 products in its pipeline, most to treat cancer, inflammatory disease, human immunodeficiency virus (HIV/AIDs), epilepsy, Parkinson ’s disease, multiple sclerosis, and other rare diseases. It regards cannabinoid-based medicines as specialty pharmaceutical products. Modulating the activity of its endocannabinoid system holds therapeutic promise in a range of disparate diseases, ranging from mood and anxiety disorders to movement disorders, which include Parkinson’s and Huntington’s diseases, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis and others
Company Overview
Intellectual Property,
Stock Overview